Private-Equity Holdings Look Overvalued. Who’s Going to Fix It?
A quiet unease is rippling through the normally self-assured world of private equity. While public markets have seen corrections and some painful revaluations, many private assets seem to be remarkably resilient, maintaining their lofty "marks" on balance sheets. This divergence is sparking growing concerns among industry observers and limited partners (LPs) alike: are private equity holdings genuinely worth what they say they are, or are we facing a systemic overvaluation problem? And critically, with regulators stretched thin, who's truly equipped to enforce accuracy?
The core of the issue lies in valuation. Unlike publicly traded stocks, which are priced daily by the market, private equity firms—the General Partners (GPs)—typically value their own portfolio companies using a mix of financial models, comparable transactions, and management projections. This "mark-to-model" approach, while standard, lacks the immediate, external validation of an open exchange. For years, this system has largely been accepted, especially during bull markets when rising tides lifted all boats. Now, with interest rates higher and economic headwinds gathering, the fidelity of these valuations is under intense scrutiny.
"It's the elephant in the room that very few want to openly discuss," notes a former enforcement attorney at the Securities and Exchange Commission (SEC), speaking on background. "Pension funds and endowments, which have allocated significant portions of their portfolios to private equity, are relying on these valuations for their own financial planning and reporting. If the underlying assets are consistently overvalued, it creates a dangerous disconnect that could have profound implications down the line."
The stakes are immense. Private equity has swelled to a staggering global asset under management (AUM) exceeding $8 trillion, according to recent industry reports. A substantial portion of this capital comes from public and corporate pension funds, university endowments, and other institutional investors, all of whom depend on accurate reporting to meet their own fiduciary duties. Inflated valuations can mask underperforming assets, delay necessary write-downs, and ultimately mislead LPs about the true health and liquidity of their investments.
What's more, this isn't just a theoretical problem. The incentive structure for GPs can, at times, lean towards higher valuations. Management fees are often calculated as a percentage of AUM, meaning a higher valuation directly translates to more revenue for the firm. While most reputable firms employ rigorous valuation committees and engage third-party appraisers, the ultimate responsibility for the "mark" rests with the GP. This inherent conflict of interest is precisely where regulators are supposed to step in.
However, the very institutions tasked with ensuring fair and accurate markets are facing significant uphill battles. The SEC, the primary regulator for investment advisers, including private equity firms, has been vocal about its focus on private funds. Yet, as the industry has exploded in size and complexity, the agency's resources haven't kept pace. "Regulators are short-staffed, plain and simple," explains a compliance consultant who works with several large private equity funds. "Auditing a multi-billion-dollar private equity fund with dozens of illiquid, highly specialized portfolio companies requires deep expertise and significant manpower. The SEC's examination teams, as capable as they are, are simply overwhelmed by the sheer volume and intricacy of the private markets."
This regulatory vacuum leaves a critical gap. While the Financial Accounting Standards Board (FASB) sets accounting principles, the interpretation and application of these principles in the private market require robust oversight. Without adequate resources, the SEC's ability to conduct thorough, proactive examinations—let alone investigations—into potentially aggressive valuation practices is severely hampered. This isn't just about catching fraud; it's about ensuring consistent, defensible methodologies across an opaque asset class.
So, who is going to fix it? Some argue that LPs themselves must exert more pressure, demanding greater transparency and independent audits. Others point to the need for increased funding and staffing for regulatory bodies, empowering them to properly police the market. There's also a growing call for industry-led initiatives to develop more standardized, transparent valuation benchmarks, though this has proven challenging given the bespoke nature of private investments.
The longer this underlying tension between stated valuations and market realities persists, the greater the risk of a more disruptive correction. As one veteran investor recently put it, "The music will eventually stop. The question isn't if, but when, and who will be left holding the bag if these marks prove to be fiction." Without a concerted effort from all stakeholders—regulators, GPs, and LPs—the integrity of a significant portion of global capital remains precariously balanced.
